Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts.

Abnormal protein kinase C levels and protein kinase C-dependent phosphorylation are biochemical alterations in brain tissue obtained from patients with Alzheimer's disease. Because many biochemical and biophysical abnormalities are found in peripheral tissues of patients with Alzheimer's disease, we studied protein kinase C levels and the in vitro phosphorylation of proteins under protein kinase C-activating conditions in fibroblasts derived from patients with Alzheimer's disease. The concentration of protein kinase C-like immunoreactivity was reduced in Alzheimer's disease samples, although the protein kinase C activity determined by the phosphorylation of exogenous histone was not. The degree of in vitro phosphorylation of an Mr 79,000 protein in the presence of protein kinase C activators was less in Alzheimer's disease than in control fibroblast cytosol, and a reduction was more prominent in cases of familial Alzheimer's disease than in sporadic Alzheimer's disease. Therefore, the aberrant phosphorylation mediated by protein kinase C is found not only in the brain but also in fibroblasts.

[1]  R. Katzman.,et al.  Decreased adhesiveness of alzheimer's disease fibroblasts: Is amyloid β‐protein precursor involved? , 1989, Annals of neurology.

[2]  K. Dobkins,et al.  Decreased levels of protein kinase C in Alzheimer brain , 1988, Brain Research.

[3]  C. Borner,et al.  Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Rasmussen,et al.  Regulation of erythrocyte Ca2+ pump activity by protein kinase C. , 1988, The Journal of biological chemistry.

[5]  W. Young,et al.  Immunochemical identification of protein kinase C isozymes as products of discrete genes. , 1987, Biochemical and biophysical research communications.

[6]  Y. Nishizuka,et al.  Identification of three additional members of rat protein kinase C family: gd‐, ϵ‐ and ξ‐subspecies , 1987 .

[7]  B. Cohen,et al.  Family study of platelet membrane fluidity in Alzheimer's disease. , 1987, Science.

[8]  N. Sims,et al.  Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease , 1987, Annals of neurology.

[9]  P. Fishman,et al.  Down-regulation of protein kinase C in rat glioma C6 cells: effects on the beta-adrenergic receptor-coupled adenylate cyclase. , 1987, Biochemical and biophysical research communications.

[10]  C. Borner,et al.  Altered protein kinase C in a mast cell variant defective in exocytosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Kessler.  Deficiency of a cholinergic differentiating factor in fibroblasts of patients with Alzheimer's disease , 1987, Annals of neurology.

[12]  F. Huang,et al.  Immunochemical characterization of rat brain protein kinase C. , 1986, The Journal of biological chemistry.

[13]  J. Goldman,et al.  Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Huang,et al.  Conversion of protein kinase C from a Ca2+-dependent to an independent form of phorbol ester-binding protein by digestion with trypsin. , 1986, Biochemical and Biophysical Research Communications - BBRC.

[15]  K. Dobkins,et al.  Protein kinase C in human brain and its inhibition by calmodulin , 1986, Brain Research.

[16]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Hunt,et al.  Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. , 1986, Brain research.

[18]  J. G. Goekoop,et al.  Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[19]  H. Rasmussen.  The calcium messenger system (1). , 1986, The New England journal of medicine.

[20]  J. Goldman,et al.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Huang,et al.  Protein kinase C as a component of a nerve growth factor-sensitive phosphorylation system in PC12 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Skaper,et al.  Tumor-promoting phorbol diester mimics two distinct neuronotrophic factors. , 1985, Brain research.

[23]  P. Blackshear,et al.  Growth factor-stimulated protein phosphorylation in 3T3-L1 cells. Evidence for protein kinase C-dependent and -independent pathways. , 1985, The Journal of biological chemistry.

[24]  E. Kaminskas,et al.  Deficient repair of DNA lesions in Alzheimer's disease fibroblasts. , 1985, Biochemical and biophysical research communications.

[25]  L. Sternberger,et al.  Aberrant neurofilament phosphorylation in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Volicer,et al.  Epinephrine-induced cyclic AMP production in skin fibroblasts from patients with dementia of Alzheimer type and controls , 1985, Neurobiology of Aging.

[27]  P. Greengard,et al.  Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Nishizuka,et al.  Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. , 1983, The Journal of biological chemistry.

[29]  F. Hefti.  Is Alzheimer disease caused by lack of nerve growth factor? , 1983, Annals of neurology.

[30]  S H Appel,et al.  A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease , 1981, Annals of neurology.

[31]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[32]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  C. Bergeron,et al.  CALMODULIN AND CALBINDIN D28K IN ALZHEIMER DISEASE , 1987, Alzheimer disease and associated disorders.

[35]  P. Greengard,et al.  Protein kinases in the brain. , 1985, Annual review of biochemistry.

[36]  J. Blass,et al.  Alzheimer's disease. A metabolic systems degeneration? , 1984, Neurochemical pathology.